Arrowhead Pharmaceuticals Inc (ARWR)
24.77
-0.23
(-0.92%)
USD |
NASDAQ |
May 17, 16:00
24.77
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Stock Buybacks (Quarterly): -429.26M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -429.26M |
December 31, 2023 | |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | 0.00 |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | -0.002M |
December 31, 2019 | -250.48M |
September 30, 2019 | -0.0003M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | -60.52M |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | -56.58M |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.2728M |
March 31, 2017 | -0.1919M |
December 31, 2016 | -12.50M |
September 30, 2016 | -52.23M |
June 30, 2016 | 0.0255M |
March 31, 2016 | -0.0255M |
December 31, 2015 | 0.00 |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | -109.82M |
December 31, 2013 | -62.82M |
September 30, 2013 | 0.00 |
June 30, 2013 | -35.36M |
March 31, 2013 | -3.757M |
December 31, 2012 | -3.332M |
September 30, 2012 | -5.483M |
June 30, 2012 | -2.705M |
March 31, 2012 | -1.232M |
December 31, 2011 | -1.472M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-429.26M
Minimum
Mar 2024
--
Maximum
Jun 2019
-84.97M
Average
-0.0001M
Median
Stock Buybacks (Quarterly) Benchmarks
89bio Inc | -21.07M |
Madrigal Pharmaceuticals Inc | -311.56M |
Viking Therapeutics Inc | -597.12M |
Akero Therapeutics Inc | -355.44M |
Sagimet Biosciences Inc | -105.75M |